Allscripts Healthcare Solutions, Inc. (MDRX)

Check out top investors' recommendation for MDRX
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Allscripts Healthcare Solutions, Inc. provides clinical, financial, connectivity, and information solutions and related professional services to hospitals, physicians, and post-acute organizations primarily in the United States and Canada. The company operates through Software Delivery, Services Delivery, Client Support, Pathway Solutions, and IT Outsourcing segments. It provides integrated clinical software applications for hospitals and health systems, which include Sunrise Enterprise suite of clinical solutions, comprising an acute care electronic health record (EHR) integrated with financial/administrative solutions, including performance management and revenue cycle/access management; and modules of the Sunrise suite that are available on a stand-alone basis, as well as additional stand-alone solutions, including emergency department information system, care management, and discharge management. The company's solutions for physician practices comprise integrated EHR and practice management functionality available either through on-premise delivery or through software-as-a-service; revenue cycle management software, which enables practices to outsource their full revenue cycle or address requirements in-house; clearinghouse services; stand-alone electronic prescribing; and document imaging solutions for physician practices. It also provides solutions for home care, hospice, skilled nursing, and other post-acute organizations ranging from an integrated EHR and financial management solution to referral management, as well as mobile solutions to deliver remote access to EHR and other capabilities on various mobile devices including iPad, iPhone, BlackBerry, Android, and Windows Mobile smartphones. In addition, the company sells related hardware, professional services, remote hosting, and IT outsourcing services. The company is headquartered in Chicago, Illinois.
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Matthew Gillmor Robert W. Baird & Co., Inc. Buy   Sep 15, '17     16.00  Sep 15, '18  N/A 
Charles Rhyee Cowen And Company Buy   Sep 11, '17     16.00  Sep 11, '18  N/A 
Steven Halper Lazard Capital Markets Buy   Aug 14, '17     17.00  Aug 14, '18  N/A 
Anthony Vendetti Maxim Group Buy   Aug 04, '17     16.00  Aug 04, '18  N/A 
John Difucci JPMorgan Buy   Jul 24, '17     16.50  Jul 24, '18  N/A 
Biren Amin Jefferies & Co. Buy   Jun 22, '17     16.50  Jun 22, '18  N/A 
Anthony Vendetti Maxim Group Buy   May 05, '17     16.00  May 05, '18  N/A 
George Hill Citi Buy   Mar 24, '17       Mar 24, '18  N/A 
Richard Close Avondale Partners LLC Buy   Jan 13, '17     17.00  Jan 13, '18  N/A 
Anthony Vendetti Maxim Group Buy   Jan 10, '17     16.00  Jan 10, '18  N/A 
Ricky Goldwasser Morgan Stanley Sell   Dec 13, '16       Dec 13, '17  N/A 
David Larsen Leerink Swann Llc Buy   Sep 23, '16     17.00  Sep 23, '17  N/A 
Ricky Goldwasser Morgan Stanley Buy   Aug 25, '16       Aug 25, '17  N/A 
David Toung Argus Research Company Buy   Aug 25, '16       Aug 25, '17  N/A 
David Larsen Leerink Swann Llc Buy   Aug 23, '16       Aug 23, '17  N/A 
Ricky Goldwasser Morgan Stanley Buy   Mar 30, '16   13.10  16.00  Mar 30, '17  -3.66% 
George Hill Citi Buy   Feb 19, '16   12.15  15.00  Feb 19, '17  1.98% 
Richard Close Avondale Partners LLC Buy   Jan 12, '16   14.27  18.00  Jan 12, '17  -17.17% 
Richard Close Avondale Partners LLC Buy   Nov 30, '15   15.23  18.00  Nov 30, '16  -28.10% 
George Hill Citi Buy   Nov 06, '15   14.91  17.00  Nov 06, '16  -31.46% 
< previous123